Understanding bone metastases: the key to the effective treatment of prostate cancer.
Fidler
Isaiah J
IJ
Department of Cancer Biology, University of Texas M. D. Cancer Center, Houston, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D009389:Neovascularization, Pathologic; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D017978:Receptors, Growth Factor / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000502:physiology
D047428:Protein Kinase Inhibitors; D017978:Receptors, Growth Factor; D016212:Transforming Growth Factor beta